Divi's Laboratories Limited (NSE:DIVISLAB)
6,667.00
-130.50 (-1.92%)
May 29, 2026, 3:30 PM IST
Divi's Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 34,140 | 4,150 | 3,630 | 1,700 | 12,148 |
Short-Term Investments | - | 31,120 | 33,350 | 39,630 | 15,269 |
Cash & Short-Term Investments | 34,140 | 35,270 | 36,980 | 41,330 | 27,417 |
Cash Growth | -3.20% | -4.62% | -10.53% | 50.75% | 31.76% |
Accounts Receivable | 29,840 | 27,310 | 21,560 | 17,930 | 24,239 |
Other Receivables | - | 2,470 | 2,050 | 1,410 | 1,045 |
Receivables | 29,840 | 29,780 | 23,610 | 19,340 | 25,283 |
Inventory | 39,540 | 32,360 | 31,840 | 30,000 | 28,286 |
Prepaid Expenses | - | 370 | 360 | 260 | 270.9 |
Other Current Assets | 7,440 | 3,030 | 3,960 | 2,190 | 2,258 |
Total Current Assets | 110,960 | 100,810 | 96,750 | 93,120 | 83,515 |
Property, Plant & Equipment | 86,350 | 64,600 | 55,130 | 49,290 | 47,875 |
Long-Term Investments | 690 | 650 | 820 | 770 | 720.1 |
Other Intangible Assets | 60 | 40 | 40 | 50 | 74.9 |
Long-Term Deferred Tax Assets | 140 | 110 | 100 | 140 | 144.7 |
Other Long-Term Assets | 2,130 | 3,110 | 1,860 | 1,020 | 1,418 |
Total Assets | 200,330 | 169,320 | 154,700 | 144,390 | 133,747 |
Accounts Payable | 12,110 | 9,100 | 8,240 | 7,620 | 7,957 |
Accrued Expenses | 600 | 3,460 | 2,440 | 2,550 | 3,235 |
Short-Term Debt | - | 20 | - | - | - |
Current Portion of Leases | 20 | - | 10 | 10 | 8.2 |
Current Income Taxes Payable | 120 | - | 430 | 20 | 16.8 |
Current Unearned Revenue | - | 10 | 10 | 10 | 7.6 |
Other Current Liabilities | 7,580 | 1,930 | 1,650 | 800 | 731.3 |
Total Current Liabilities | 20,430 | 14,520 | 12,780 | 11,010 | 11,956 |
Long-Term Leases | 50 | 20 | 20 | 30 | 28.7 |
Long-Term Deferred Tax Liabilities | 4,690 | 5,090 | 5,820 | 5,370 | 4,214 |
Other Long-Term Liabilities | 7,550 | - | 370 | 310 | 267.1 |
Total Liabilities | 32,720 | 19,630 | 18,990 | 16,720 | 16,465 |
Common Stock | 530 | 530 | 530 | 530 | 530.9 |
Additional Paid-In Capital | - | 800 | 800 | 800 | 798.8 |
Retained Earnings | - | 148,050 | 134,120 | 126,090 | 115,797 |
Comprehensive Income & Other | 167,080 | 310 | 260 | 250 | 155.1 |
Shareholders' Equity | 167,610 | 149,690 | 135,710 | 127,670 | 117,282 |
Total Liabilities & Equity | 200,330 | 169,320 | 154,700 | 144,390 | 133,747 |
Total Debt | 70 | 40 | 30 | 40 | 36.9 |
Net Cash (Debt) | 34,070 | 35,230 | 36,950 | 41,290 | 27,380 |
Net Cash Growth | -3.29% | -4.66% | -10.51% | 50.80% | 31.89% |
Net Cash Per Share | 128.36 | 132.71 | 139.19 | 155.54 | 103.14 |
Filing Date Shares Outstanding | 265.28 | 265.47 | 265.47 | 265.47 | 265.47 |
Total Common Shares Outstanding | 265.28 | 265.47 | 265.47 | 265.47 | 265.47 |
Working Capital | 90,530 | 86,290 | 83,970 | 82,110 | 71,560 |
Book Value Per Share | 631.83 | 563.87 | 511.21 | 480.92 | 441.79 |
Tangible Book Value | 167,550 | 149,650 | 135,670 | 127,620 | 117,207 |
Tangible Book Value Per Share | 631.60 | 563.72 | 511.06 | 480.73 | 441.51 |
Land | - | 2,020 | 1,950 | 1,940 | 1,727 |
Machinery | - | 55,000 | 48,630 | 45,770 | 39,860 |
Construction In Progress | - | 10,220 | 7,780 | 2,120 | 4,699 |